An Adhesion Reduction Plan in the Management of the Surgical Open Abdomen
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether an adhesion reduction plan, consisting of early adhesion prevention and application of a bioresorbable membrane is effective in reducing the severity of adhesions and the incidence of complications in managing the open abdomen in trauma and emergency general surgery.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Adhesions are a common consequence of abdominal surgery. Trauma and emergency general surgery patients may require an open abdomen and undergo a series of abdominal operations, which may be increasingly complicated by the presence of adhesions. Adhesions appear soon after the initial operation and gradually mature within days. The effects of adhesion development on subsequent surgery may include: increased procedure time; difficulty differentiating, exposing, and accessing tissue planes; and increased risk of inadvertent enterotomy. Complications of adhesions include enteric obstruction and enterocutaneous fistulae. This study will determine whether an adhesion reduction plan, consisting of early adhesion prevention and application of a bioresorbable membrane is effective in reducing the extent and severity of adhesions and the incidence of complications in managing the open abdomen in trauma and emergency general surgery.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Adhesion Reduction Plan Lysis of adhesions and application of Seprafilm |
Procedure: Adhesion Reduction Plan
Lysis of adhesions and application of a minimum of 4 sheets of a sodium hyaluronate-based bioresorbable membrane
Other Names:
|
No Intervention: Standard Management Standard management and no application of Seprafilm |
Outcome Measures
Primary Outcome Measures
- Extent and severity of adhesions [Each abdominal re-entry and re-exploration]
Secondary Outcome Measures
- Time for lysis of adhesions [Each abdominal re-entry and re-exploration]
- Incidence of complications [Hospital admission]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Trauma patients with open abdomen after initial laparotomy
-
Emergency surgery patients with open abdomen after initial laparotomy
-
Able to obtain consent from patient or LAR before any research initiated
Exclusion Criteria:
-
Seprafilm application at initial laparotomy
-
Patient is a prisoner
-
Inability to obtain informed consent
-
Consentable person does not speak English
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | University of Maryland Medical Center | Baltimore | Maryland | United States | 21201-1595 |
Sponsors and Collaborators
- University of Maryland, Baltimore
- Genzyme, a Sanofi Company
Investigators
- Principal Investigator: William C. Chiu, M.D., University of Maryland, College Park
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HP-00043289